PRIMARY SCLEROSING CHOLANGITIS (PSC)
Clinical trials for PRIMARY SCLEROSING CHOLANGITIS (PSC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SCLEROSING CHOLANGITIS (PSC) trials appear
Sign up with your email to follow new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills vs. placebo: can gut bugs tame a tough liver disease?
Disease control Not yet recruitingThis study is testing whether a fecal microbiota transplant (FMT) can help control primary sclerosing cholangitis (PSC), a rare and serious liver disease often linked with inflammatory bowel disease (IBD). Researchers will compare FMT capsules to placebo capsules in 72 patients w…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Antibiotic tested as potential new weapon against double disease
Disease control Not yet recruitingThis small pilot study is testing if the antibiotic vancomycin, taken by mouth, can safely improve symptoms of active ulcerative colitis in adults who also have a liver disease called primary sclerosing cholangitis. Fourteen participants will take either the antibiotic or a place…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS (PSC)
Phase: PHASE2 • Sponsor: McMaster University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC